140 related articles for article (PubMed ID: 10728909)
21. Phase II trial of etoposide in leiomyosarcoma of the uterus: a Gynecologic Oncology Group study.
Thigpen T; Blessing JA; Yordan E; Valea F; Vaccarello L
Gynecol Oncol; 1996 Oct; 63(1):120-2. PubMed ID: 8898180
[TBL] [Abstract][Full Text] [Related]
22. Etoposide-containing regimens with autologous bone marrow transplantation in children with malignant brain tumors.
Busca A; Miniero R; Besenzon L; Cordero di Montezemolo L; Cenni M; Fagioli F; Sandri A; Vassallo E; Ricardi U; Madon E
Childs Nerv Syst; 1997; 13(11-12):572-7. PubMed ID: 9454971
[TBL] [Abstract][Full Text] [Related]
23. Treatment of high-risk medulloblastoma and other primitive neuroectodermal tumors with reduced dose craniospinal radiation therapy and multi-agent nitrosourea-based chemotherapy.
Prados MD; Wara W; Edwards MS; Ater J; Rabbit J; Lamborn K; Davis R; Levin VA
Pediatr Neurosurg; 1996 Oct; 25(4):174-81. PubMed ID: 9293544
[TBL] [Abstract][Full Text] [Related]
24. Phase II study of prolonged oral therapy with etoposide (VP16) for patients with recurrent malignant glioma.
Fulton D; Urtasun R; Forsyth P
J Neurooncol; 1996 Feb; 27(2):149-55. PubMed ID: 8699237
[TBL] [Abstract][Full Text] [Related]
25. Treatment with oral etoposide for childhood recurrent ependymomas.
Sandri A; Massimino M; Mastrodicasa L; Sardi N; Bertin D; Basso ME; Todisco L; Paglino A; Perilongo G; Genitori L; Valentini L; Ricardi U; Gandola L; Giangaspero F; Madon E
J Pediatr Hematol Oncol; 2005 Sep; 27(9):486-90. PubMed ID: 16189442
[TBL] [Abstract][Full Text] [Related]
26. Recurrent intracranial ependymoma in children: salvage therapy with oral etoposide.
Chamberlain MC
Pediatr Neurol; 2001 Feb; 24(2):117-21. PubMed ID: 11275460
[TBL] [Abstract][Full Text] [Related]
27. Thiotepa and etoposide treatment of recurrent malignant gliomas: phase I study.
Balmaceda C; Fetell MR; Hesdorffer C
Cancer Chemother Pharmacol; 1997; 40(1):72-4. PubMed ID: 9137533
[TBL] [Abstract][Full Text] [Related]
28. Etoposide treatment in recurrent medulloblastoma.
Boor R; Huber A; Gutjahr P
Neuropediatrics; 1994 Feb; 25(1):39-41. PubMed ID: 8208349
[TBL] [Abstract][Full Text] [Related]
29. Single-agent erlotinib versus oral etoposide in patients with recurrent or refractory pediatric ependymoma: a randomized open-label study.
Jakacki RI; Foley MA; Horan J; Wang J; Kieran MW; Bowers DC; Bouffet E; Zacharoulis S; Gill SC
J Neurooncol; 2016 Aug; 129(1):131-8. PubMed ID: 27287856
[TBL] [Abstract][Full Text] [Related]
30. High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. Children's Cancer Group.
Dunkel IJ; Boyett JM; Yates A; Rosenblum M; Garvin JH; Bostrom BC; Goldman S; Sender LS; Gardner SL; Li H; Allen JC; Finlay JL
J Clin Oncol; 1998 Jan; 16(1):222-8. PubMed ID: 9440746
[TBL] [Abstract][Full Text] [Related]
31. Phase II study of a radiotherapy/etoposide combination for patients with newly malignant gliomas.
Beauchesne P; Soler C; Rusch P; Fotso MJ; Duthel R; Schmitt T; Brunon J
Cancer Chemother Pharmacol; 1999; 44(3):210-6. PubMed ID: 10453722
[TBL] [Abstract][Full Text] [Related]
32. Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Rose PG; Blessing JA; Van Le L; Waggoner S
Gynecol Oncol; 1998 Aug; 70(2):263-6. PubMed ID: 9740702
[TBL] [Abstract][Full Text] [Related]
33. Toxicity and efficacy of carboplatin and etoposide in conjunction with disruption of the blood-brain tumor barrier in the treatment of intracranial neoplasms.
Williams PC; Henner WD; Roman-Goldstein S; Dahlborg SA; Brummett RE; Tableman M; Dana BW; Neuwelt EA
Neurosurgery; 1995 Jul; 37(1):17-27; discussion 27-8. PubMed ID: 8587686
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of vincristine and etoposide with escalating cyclophosphamide in poor-prognosis pediatric brain tumors.
Ziegler DS; Cohn RJ; McCowage G; Alvaro F; Oswald C; Mrongovius R; White L;
Neuro Oncol; 2006 Jan; 8(1):53-9. PubMed ID: 16443948
[TBL] [Abstract][Full Text] [Related]
35. Cisplatin in the treatment of recurrent childhood primary brain tumors.
Walker RW; Allen JC
J Clin Oncol; 1988 Jan; 6(1):62-6. PubMed ID: 2826716
[TBL] [Abstract][Full Text] [Related]
36. Intra-arterial cisplatin plus oral etoposide for the treatment of recurrent malignant glioma: a phase II study.
Ashby LS; Shapiro WR
J Neurooncol; 2001 Jan; 51(1):67-86. PubMed ID: 11349883
[TBL] [Abstract][Full Text] [Related]
37. Hyperfractionated craniospinal radiotherapy and adjuvant chemotherapy for children with newly diagnosed medulloblastoma and other primitive neuroectodermal tumors.
Allen JC; Donahue B; DaRosso R; Nirenberg A
Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1155-61. PubMed ID: 8985038
[TBL] [Abstract][Full Text] [Related]
38. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.
Grier HE; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore S; Rausen AR; Vietti TJ; Miser JS
N Engl J Med; 2003 Feb; 348(8):694-701. PubMed ID: 12594313
[TBL] [Abstract][Full Text] [Related]
39. Myeloablative chemotherapy with autologous bone marrow rescue in young children with recurrent malignant brain tumors.
Guruangan S; Dunkel IJ; Goldman S; Garvin JH; Rosenblum M; Boyett JM; Gardner S; Merchant TE; Gollamudi S; Finlay JL
J Clin Oncol; 1998 Jul; 16(7):2486-93. PubMed ID: 9667268
[TBL] [Abstract][Full Text] [Related]
40. VIP (etoposide, ifosfamide, cisplatin) in adult patients with recurrent or refractory Ewing sarcoma family of tumors.
El Weshi A; Memon M; Raja M; Bazarbashi S; Rahal M; El Foudeh M; Pai C; Allam A; El Hassan I; Ezzat A
Am J Clin Oncol; 2004 Oct; 27(5):529-34. PubMed ID: 15596925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
